NEW YORK STATE COMMON RETIREMENT FUND - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$800
+19.9%
23,082
+0.2%
0.00%0.0%
Q1 2024$667
+25.8%
23,044
-0.3%
0.00%0.0%
Q4 2023$530
+37.0%
23,103
-0.4%
0.00%0.0%
Q3 2023$387
-39.0%
23,201
+1.0%
0.00%0.0%
Q2 2023$634
-0.5%
22,964
-17.1%
0.00%0.0%
Q1 2023$637
+110.9%
27,692
+0.1%
0.00%
Q4 2022$302
-99.9%
27,673
-0.1%
0.00%
Q3 2022$233,000
+32.4%
27,697
+24.2%
0.00%
Q2 2022$176,000
-77.6%
22,300
-32.8%
0.00%
-100.0%
Q1 2022$786,000
-30.7%
33,206
+0.1%
0.00%0.0%
Q4 2021$1,134,000
+113.6%
33,161
+10.8%
0.00%0.0%
Q3 2021$531,000
-66.9%
29,938
-16.4%
0.00%
-50.0%
Q2 2021$1,606,000
+125.6%
35,790
+30.1%
0.00%
+100.0%
Q1 2021$712,000
+28.5%
27,5000.0%0.00%0.0%
Q4 2020$554,000
+35.5%
27,500
+31.6%
0.00%0.0%
Q3 2020$409,000
+10.8%
20,9000.0%0.00%
Q2 2020$369,000
+238.5%
20,900
+34.8%
0.00%
Q1 2020$109,0000.0%15,5000.0%0.00%
Q4 2019$109,000
-41.4%
15,5000.0%0.00%
Q3 2019$186,000
-1.1%
15,5000.0%0.00%
Q2 2019$188,000
+60.7%
15,500
+14.0%
0.00%
Q1 2018$117,000
-44.8%
13,600
+33.3%
0.00%
Q4 2017$212,000
+58.2%
10,200
+34.2%
0.00%
Q3 2017$134,000
+55.8%
7,6000.0%0.00%
Q2 2017$86,000
-11.3%
7,600
-0.0%
0.00%
Q1 2017$97,0007,6010.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$84,864,19121.18%
Cannon Global Investment Management, LLC 69,900$2,422,03511.28%
ADAR1 Capital Management, LLC 1,603,932$55,576,24410.49%
Checkpoint Capital L.P. 355,000$12,300,7507.42%
Fairmount Funds Management LLC 931,890$32,289,9893.65%
BVF INC/IL 3,319,290$115,013,3993.22%
RTW INVESTMENTS, LP 5,286,404$183,173,8992.84%
Kynam Capital Management, LP 800,000$27,720,0002.14%
683 Capital Management, LLC 604,449$20,944,1581.58%
Birchview Capital, LP 48,000$1,663,2001.54%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders